Skip to content
TrialScanner

NCT03834753

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Phase 3CompletedOTLKLead

Registry record

Lead sponsor
Outlook Therapeutics, Inc.
Conditions
Age-related Macular Degeneration; Neovascular Age-related Macular Degeneration; Wet Macular Degeneration
Primary completion
Jun 7, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03834753 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03834753: A Clinical Effectiveness... | TrialScanner